Veterinary Diagnostics Institute (VDxI) Launches the First and Only Species-Specific Blood Test for the Detection of Heart Disease in Dogs
Posted on: Wednesday, 26 July 2006, 21:00 CDT
Veterinary Diagnostics Institute Inc. (VDxI), a specialty diagnostics lab services provider for companion animals, announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs. Canine CardioCare is patent pending.
"Natriuretic peptide testing for heart disease is already the standard of care in humans and it should also be for dogs," said Dr. Steven Ness, president and co-founder of VDxI. "Heart disease is often asymptomatic and many dog owners are unaware their pet has heart disease until disease reaches a state of heart failure. Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds."
In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease. NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states.
"With over 75M dogs in the USA, it is estimated that as many as 15 percent have heart disease," said Randy Ringold, CEO and founder of VDxI. "Used as part of a general wellness screen, we estimate that the market potential for Canine CardioCare is over $900 million."
About Veterinary Diagnostics Institute
VDxI, a California corporation, is a specialty diagnostics laboratory service provider dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with academia and in-vitro diagnostics manufacturers, VDxI addresses a growing demand in the veterinary healthcare service for advanced diagnostics. The United States has the world's largest population of companion animals, over 150 million, with over $20 billion spent on veterinary care each year. For more information see www.vdxinstitute.com.
Source: Business Wire
Related Articles
- H3N2 Influenza Unlikely to Spread Between Humans, K-State Infectious Disease and Diagnostics Experts Say; Swine Exhibits at Fairs are Safe With Proper Hygiene
- Tiny Device To "Sniff Out" Disease, Heart Attacks, Poison And Environmental Pollution
- Diseased Heart Valve Replaced Through Small Chest Incision
- Applied NeuroSolutions Achieves Q2 2008 Alzheimer's Disease Serum Diagnostic Development Program Milestone
- Veterinary Diagnostics Institute (VDxI) Announces Webster Veterinary Supply As the Exclusive Distributor of VDxI's CardioCare (NT-proBNP) for the Detection of Heart Disease
- Gumshoe Sniffs for Elvis the Dog: Ailing Canine Gone Since May
- GE Healthcare Announces the First in a Series of Major Multi-Center, Multi-Patient Trials to Validate Clinical Efficacy of LightSpeed VCT As a Coronary Artery Disease (CAD) Diagnostic Tool
- Crohn's Disease: New Diagnostic Technology
- Cholesterol May Link Gum Disease, Heart Disease
 |
 |
User Comments (0)
RSS Feeds